Medical technology company Masimo has been facing off with Apple in court since 2020, and while Masimo has scored some wins, ...

Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results , with sales up 7.9% year on year to $370.9 million. The ...

Second Quarter 2025 Results Key Financial Results Revenue: US$370.9m (down 25% from 2Q ...

Masimo Corp (MASI) reports robust earnings growth and outlines strategic advancements in healthcare technology amidst tariff ...

Q2 2025 Management View CEO Catherine M. Szyman reported "our core Healthcare business delivered strong growth and earnings performance. Revenue was $370 million, and we achieved earnings per share ...

Masimo (Nasdaq: MASI) shares dipped after hours today on second-quarter results that came in ahead of the consensus forecast.

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Masimo Corp. (MASI) on Tuesday reported second-quarter profit of $51.3 million. On a per-share basis, the Irvine, California-based company said it had ...

Apple asked a U.S. appeals court on Monday to overturn a trade tribunal's decision which forced it to remove blood-oxygen ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it ...

Now, the former chief operating officer has been tapped to be an executive vice president at Becton, Dickinson and Co. and ...

Masimo SET ® pulse oximetry has been clinically proven to help care teams enhance patient safety and improve patient outcomes; in fact, more than 100 independent and objective studies have shown ...

The stock price of Masimo Corporation, a medical devices company best known for its remote patient monitoring systems, reached its all-time high of $287 just last week before a recent decline ...